FDA Suspends Licence of Mumbai’s Premier Hotel Amid Safety Concerns

The Food and Drug Administration (FDA) announced today that it has suspended the operating licence of a leading hotel in Mumbai, citing serious hygiene and safety violations. The decision follows a complaint filed by a judge of the Bombay High Court, who noted that a fly was found on his table during a recent inspection of the hotel’s premises. The FDA’s action is effective immediately and requires the hotel to address the identified deficiencies before its licence can be reinstated. Hotel management has said it will cooperate with the authorities and implement corrective measures as soon as possible. The suspension is part of the FDA’s broader effort to enforce food safety standards across the hospitality sector in the city.